Lam Research (NASDAQ:LRCX – Get Free Report) updated its second quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.770-0.970 for the period, compared to the consensus earnings per share estimate of 0.840. The company issued revenue guidance of $4.0 billion-$4.6 billion, compared to the consensus revenue estimate of $4.2 billion. Lam Research also updated its Q2 guidance to $0.77-0.97 EPS.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on LRCX. Stifel Nicolaus reaffirmed a “buy” rating and issued a $100.00 target price (down from $105.00) on shares of Lam Research in a research report on Thursday. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $100.00 target price on shares of Lam Research in a research report on Thursday. Wells Fargo & Company reduced their target price on shares of Lam Research from $88.00 to $85.00 and set an “equal weight” rating on the stock in a research report on Thursday. Mizuho reduced their target price on shares of Lam Research from $105.00 to $95.00 and set an “outperform” rating on the stock in a research report on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of Lam Research from $110.00 to $95.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and a consensus price target of $97.03.
Read Our Latest Stock Report on LRCX
Lam Research Stock Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.05. The firm had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $4.06 billion. Lam Research had a net margin of 25.68% and a return on equity of 48.71%. The business’s quarterly revenue was up 19.7% compared to the same quarter last year. During the same quarter last year, the firm posted $6.85 EPS. Equities research analysts anticipate that Lam Research will post 3.23 earnings per share for the current year.
Lam Research Cuts Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Tuesday, September 17th were paid a $0.23 dividend. This represents a $0.92 annualized dividend and a dividend yield of 1.17%. The ex-dividend date of this dividend was Tuesday, September 17th. Lam Research’s dividend payout ratio (DPR) is presently 31.72%.
Insider Transactions at Lam Research
In other news, CAO Christina Correia sold 647 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $817.51, for a total value of $528,928.97. Following the transaction, the chief accounting officer now owns 4,267 shares in the company, valued at $3,488,315.17. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.29% of the company’s stock.
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Read More
- Five stocks we like better than Lam Research
- Top Biotech Stocks: Exploring Innovation Opportunities
- Texas Roadhouse Stock Steering for New Highs This Year
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is the S&P/TSX Index?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.